Specialty: Medical Oncology Consultant
Telephone: +35722100945
Other Telephones: +35799457262
Fax: +35722100947
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.


Medical School:
Semmelweis University Of Medicine

Specialty training in the UK.
Poole Hospital, Royal Marsden Hospital, The Royal Bournemouth Hospital
MSc in Medical Oncology, Newcastle


Nicosia General Hospital, Cyprus

Clinical Research Fellow in Medical Oncology

Member of the European Society Of Medical Oncology (ESMO)
Member of the American Society Of Clinical Oncology (ASCO)
Member of the Oncology Multi-Disciplinary Teams
Member of Cyprus Medical Association
Member of Cyprus Oncology Society
Member of the Oncology Department at YGIA Polyclinic Private Hospital

Academic Interests:
Lung, Breast, Gastro-intestinal, Renal Cancers, Sarcomas and Melanomas.


Professional Highlights:
Involvement International Phase 2 and Phase 3 trials.
Development of Acute Oncology Service.
Development of End of Treatment Assessment-Oncology follow up and Assessment Guidelines.
Development of Oncology-Triage Guidelines.
Peer Review member of the European Medical Journal of Oncology.
Co - Developer of Electronic Prescribing System of Oncology
Co-author of the Medical Oncology Handbook for RBCH.
Development of Oncology e-learning modules.
Development of Patient Educational Neutropenic Sepsis DVD.
Training of Nurses & Doctors in Oncology, (Dorset Cancer Network, Royal Marsden Hospital).


Dunlop, M. G., S. E. Dobbins, et al. (2012). "Common variation near CDKN1A, POLD3 and SHROOM2 influences colorectal cancer risk." Nat Genet 44(7): 770-776.
G.Astras,Hickish.T ,L.Purandare Diagnosis and managemnet of Isolated Pituitary Metastasis from adenocarcinoma of uknown origin presenting as losss of libido. July 2012
G.Astras ,L.Purandare-Use of Avastin in cutaneous metastatic breast cancer July 2012
Geldart, T. and G. Astras (2011). "Isolated CNS relapse in human epidermal growth factor receptor 2-positive esophagogastric cancer: effective treatment with trastuzumab after failure of surgery and radiotherapy." J Clin Oncol 29(23): e664-665.
Hickish, T., G. Astras, et al. (2009). "Glucose intolerance during adjuvant chemotherapy for breast cancer." J Natl Cancer Inst 101(7): 537.
An epidemiological assessement of the lifestyle Factors which may be associated with the development of Barretts oesophagus-CARBO study- Dr David Kerr,Dr T.Hickish,Dr.G.Astras,Dr.J.Ainley Jan 2007